OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Biological effects of IL-15 on immune cells and its potential for the treatment of cancer
Shuling Zhang, Jianzhu Zhao, Xueli Bai, et al.
International Immunopharmacology (2020) Vol. 91, pp. 107318-107318
Closed Access | Times Cited: 49
Shuling Zhang, Jianzhu Zhao, Xueli Bai, et al.
International Immunopharmacology (2020) Vol. 91, pp. 107318-107318
Closed Access | Times Cited: 49
Showing 1-25 of 49 citing articles:
Innate lymphoid cells and cancer
Nicolas Jacquelot, Cyril Seillet, Éric Vivier, et al.
Nature Immunology (2022) Vol. 23, Iss. 3, pp. 371-379
Open Access | Times Cited: 124
Nicolas Jacquelot, Cyril Seillet, Éric Vivier, et al.
Nature Immunology (2022) Vol. 23, Iss. 3, pp. 371-379
Open Access | Times Cited: 124
Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma
Paolo F. Caimi, Gabriela Pacheco Sánchez, Ashish Sharma, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 87
Paolo F. Caimi, Gabriela Pacheco Sánchez, Ashish Sharma, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 87
Research progress of interleukin-15 in cancer immunotherapy
Menghan Cai, Xuan Huang, Xiting Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 41
Menghan Cai, Xuan Huang, Xiting Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 41
Optimizing the manufacturing and antitumour response of CAR T therapy
Yutong Liu, Adam S. Sperling, Eric L. Smith, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 4, pp. 271-285
Closed Access | Times Cited: 27
Yutong Liu, Adam S. Sperling, Eric L. Smith, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 4, pp. 271-285
Closed Access | Times Cited: 27
Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations
Xiang Chen, Lingjuan Chen, Xiaofei Peng, et al.
Translational Oncology (2023) Vol. 40, pp. 101851-101851
Open Access | Times Cited: 24
Xiang Chen, Lingjuan Chen, Xiaofei Peng, et al.
Translational Oncology (2023) Vol. 40, pp. 101851-101851
Open Access | Times Cited: 24
Exploring exercise-driven exerkines: unraveling the regulation of metabolism and inflammation
Nihong Zhou, Lijing Gong, Enming Zhang, et al.
PeerJ (2024) Vol. 12, pp. e17267-e17267
Open Access | Times Cited: 9
Nihong Zhou, Lijing Gong, Enming Zhang, et al.
PeerJ (2024) Vol. 12, pp. e17267-e17267
Open Access | Times Cited: 9
The role of chronic low-grade inflammation in the development of sarcopenia: Advances in molecular mechanisms
Ying Cheng, Shangjin Lin, Ziyi Cao, et al.
International Immunopharmacology (2025) Vol. 147, pp. 114056-114056
Closed Access | Times Cited: 1
Ying Cheng, Shangjin Lin, Ziyi Cao, et al.
International Immunopharmacology (2025) Vol. 147, pp. 114056-114056
Closed Access | Times Cited: 1
Cancer Immunotherapy and Delivery System: An Update
Ming Yang, Olamide Tosin Olaoba, Chunye Zhang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1630-1630
Open Access | Times Cited: 31
Ming Yang, Olamide Tosin Olaoba, Chunye Zhang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1630-1630
Open Access | Times Cited: 31
Exercise-induced IL-15 acted as a positive prognostic implication and tumor-suppressed role in pan-cancer
Zhiwen Luo, Zhong He, Haocheng Qin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29
Zhiwen Luo, Zhong He, Haocheng Qin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29
IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside
Sogand Vahidi, Arefeh Zabeti Touchaei, Ali Akbar Samadani
International Immunopharmacology (2024) Vol. 133, pp. 112156-112156
Closed Access | Times Cited: 7
Sogand Vahidi, Arefeh Zabeti Touchaei, Ali Akbar Samadani
International Immunopharmacology (2024) Vol. 133, pp. 112156-112156
Closed Access | Times Cited: 7
Combined therapy of CAR-IL-15/IL-15Rα-T cells and GLIPR1 knockdown in cancer cells enhanced anti-tumor effect against gastric cancer
Jianbin Ye, Qiaoyuan Liu, Yunxuan He, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Jianbin Ye, Qiaoyuan Liu, Yunxuan He, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Heterodimeric IL-15 in Cancer Immunotherapy
Cristina Bergamaschi, Vasiliki Stravokefalou, Dimitris Stellas, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 837-837
Open Access | Times Cited: 37
Cristina Bergamaschi, Vasiliki Stravokefalou, Dimitris Stellas, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 837-837
Open Access | Times Cited: 37
Hydrogel-based co-delivery of CIK cells and oncolytic adenovirus armed with IL12 and IL15 for cancer immunotherapy
Yanan Du, Wei Qian, Lijing Zhao, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113110-113110
Open Access | Times Cited: 24
Yanan Du, Wei Qian, Lijing Zhao, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113110-113110
Open Access | Times Cited: 24
Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment
Shilpi Singh, Debashis Barik, Ananta Prasad Arukha, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2621-2621
Open Access | Times Cited: 14
Shilpi Singh, Debashis Barik, Ananta Prasad Arukha, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2621-2621
Open Access | Times Cited: 14
Nanotechnology Applications in Breast Cancer Immunotherapy
Ruijie Wang, Pramod Kumar, Moataz Reda, et al.
Small (2023)
Closed Access | Times Cited: 13
Ruijie Wang, Pramod Kumar, Moataz Reda, et al.
Small (2023)
Closed Access | Times Cited: 13
Natural killer cells in sepsis: Friends or foes?
Fangjie Wang, Yiqin Cui, Dongmei He, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Fangjie Wang, Yiqin Cui, Dongmei He, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Role of the granzyme family in rheumatoid arthritis: Current Insights and future perspectives
Yixin Zheng, Jianan Zhao, Yu Shan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Yixin Zheng, Jianan Zhao, Yu Shan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
New insights into the stemness of adoptively transferred T cells by γc family cytokines
Mengshi Luo, Wenjian Gong, Yuewen Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Mengshi Luo, Wenjian Gong, Yuewen Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Adipokines in Breast Cancer: Decoding Genetic and Proteomic Mechanisms Underlying Migration, Invasion, and Proliferation
Anne Ließem, Uwe Leimer, Günter Germann, et al.
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 79-102
Open Access
Anne Ließem, Uwe Leimer, Günter Germann, et al.
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 79-102
Open Access
IL-15/IL-15Rα-secreting bioengineered adipocytes reactivate NK/CD8+ T cells in ovarian and colon cancer ascites
Yuanxin Zhang, Tong Li, A P Liu, et al.
International Journal of Biological Macromolecules (2025), pp. 140559-140559
Closed Access
Yuanxin Zhang, Tong Li, A P Liu, et al.
International Journal of Biological Macromolecules (2025), pp. 140559-140559
Closed Access
Optimized expression of human interleukin-15 in Nicotiana benthamiana and in vitro assessment of its activity on Human Keratinocytes
Chalatorn Charnsatabut, Pipob Suwanchaikasem, Kaewta Rattanapisit, et al.
Biotechnology Reports (2025), pp. e00889-e00889
Open Access
Chalatorn Charnsatabut, Pipob Suwanchaikasem, Kaewta Rattanapisit, et al.
Biotechnology Reports (2025), pp. e00889-e00889
Open Access
The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances
Paula Morcillo-Martín-Romo, Javier Valverde-Pozo, María Ortiz-Bueno, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 857-857
Open Access
Paula Morcillo-Martín-Romo, Javier Valverde-Pozo, María Ortiz-Bueno, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 857-857
Open Access
Cytokine-based immunotherapy for gastric cancer: targeting inflammation for tumor control
Mathan Muthu Chinakannu Marimuthu, Bhavani Sowndharya Balamurugan, Sundaram Vickram, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Mathan Muthu Chinakannu Marimuthu, Bhavani Sowndharya Balamurugan, Sundaram Vickram, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
NK cells as powerful therapeutic tool in cancer immunotherapy
Mao Huang, Yixuan Liu, Qijia Yan, et al.
Cellular Oncology (2024) Vol. 47, Iss. 3, pp. 733-757
Closed Access | Times Cited: 3
Mao Huang, Yixuan Liu, Qijia Yan, et al.
Cellular Oncology (2024) Vol. 47, Iss. 3, pp. 733-757
Closed Access | Times Cited: 3
Promising Cytokine Adjuvants for Enhancing Tuberculosis Vaccine Immunity
Xuezhi Cao, Yang‐Xin Fu, Peng Hua
Vaccines (2024) Vol. 12, Iss. 5, pp. 477-477
Open Access | Times Cited: 3
Xuezhi Cao, Yang‐Xin Fu, Peng Hua
Vaccines (2024) Vol. 12, Iss. 5, pp. 477-477
Open Access | Times Cited: 3
